Wayne gave many hints in last AGM to support Eire view point:
- No more funding from us,
if we remain a major holder, then we will be forced to contribute.
Wayne also alluded on many occasions that the Vax was a too big of a project for Admedus to handle, so I also have the view point that someone will be buying a big chunk out from VAX, that someone will have a controlling share, anywhere above the 51%, AHZ gets paid back whatever they invested in, while retaining a 10% to 15% Share free carried.
If the Vaccine becomes a reality say in 5 years from now, we will still receive a cut out of the profits.
Upcoming Immunotherapies Deal (???), page-6
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.50 |
Change
-0.400(3.10%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $12.71 | $12.71 | $12.30 | $131.3K | 10.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 85 | $11.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.50 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |